Altria Group (Altria Group) Risk Assessment

View and export this data going back to 1985. Start your Free Trial

What is Altria Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Altria Group is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Altria Group's Risk Assessment

For the Tobacco subindustry, Altria Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altria Group's Risk Assessment Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Altria Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Altria Group's Risk Assessment falls into.

Altria Group (NYSE:MO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Altria Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of Altria Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Altria Group (Altria Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Altria Group Inc (NYSE:MO) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

MO:Mexico 1MO:Italy PHM7d:UK 0R31:UK PHM7:Germany PHM7:Germany PHM7:Germany PHM7:Germany MO:Chile MOOO34:Brazil ALTR:Austria MO:Argentina

Address

6601 West Broad Street, Richmond, VA, USA, 23230

Website

https://www.altria.com

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Horizon Innovations and Helix Innovations. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 42% annual share in 2022. Altria holds a 42% stake in cannabis manufacturer Cronos, has acquired Njoy Holdings in 2023, and recently exited its strategic investment in Juul Labs.

Executives

Clarke Ian L.t.	director	6601 W BROAD ST, RICHMOND VA 23230
Robert Matthew Davis	director	6601 W. BROAD STREET, RICHMOND VA 23230
Jacinto J Hernandez	director	777 HIDDEN RIDGE, IRVING TX 75038
Mario Max Yzaguirre	director	1515 WEST 190TH STREET, SUITE 275, GARDENA CA 90248
Marjorie Mary Connelly	director	2580 PALMER DR, KESWICK VA 22947
Ellen R Strahlman	director	ALTRIA GROUP, INC., 6601 W. BROAD STREET, RICHMOND VA 23230
Nabil Y Sakkab	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Virginia E Shanks	director	4170 CAUGHLIN PARKWAY, RENO NV 89519
Casteen John T Iii	director	301 S. COLLEGE STREET, 30TH FLOOR, NC0630, CHARLOTTE NC 28288-0630
Kathryn B. Mcquade	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Kiely W Leo Iii	director
Mark Newman	director	1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Kelly Ennis Debra J	director	4405 A INTERNATIONAL BLVD, NORCROSS GA 30093
Surgner W Hildebrandt Jr	officer: VP, Corp. Sec'y & Assoc. GC	6601 WEST BROAD STREET, RICHMOND VA 23230
Daniel J Bryant	officer: Vice President & Treasurer	6601 WEST BROAD STREET, RICHMOND VA 23230